Optimising the benefits of oral anticoagulants for atrial fibrillation

+Practice
In print
Heartbeat

Optimising the benefits of oral anticoagulants for atrial fibrillation

Chris Ellis

Chris Ellis

ECG
[Image: Supplied]

Oral anticoagulation reduces the rate of thromboembolism in patients with atrial fibrillation. Here, consultant cardiologist Chris Ellis reviews the importance of regular follow-up

This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.25 credits for continuing professional development purposes (1, Educate small, BACK panel - grey
References

1. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139–51.

2. Harper P, Chang A, Stephens M. The changing use of anticoagulants in New Zealand. NZ Med J 2022;135(1554):35–43.